Netherlands Wound Care Management Devices Market Size and Share

Netherlands Wound Care Management Devices Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Netherlands Wound Care Management Devices Market Analysis by Mordor Intelligence

The Netherlands wound care management devices market is valued at USD 220.46 million in 2025 and is projected to reach USD 280.69 million by 2030, expanding at a 4.95% CAGR over the forecast period. Demand growth is fueled by a rising elderly population, wider use of negative-pressure and sensor-enabled therapies, and the national Fast-Track protocol that has compressed specialist referral times and redirected resources toward higher-value technologies. Hospitals are moving from volume-based purchasing to outcome-focused procurement, prompting manufacturers to emphasize total cost-of-care propositions rather than product features. Retail channels are gaining traction as self-management products and e-commerce platforms make professional-grade dressings accessible to patients. Sustainability mandates, especially restrictions on single-use plastics, are accelerating innovation in bio-based materials and encouraging circular business models for devices and packaging.

Key Report Takeaways

  • By product, wound care devices led with 67.44% of the Netherlands wound care management devices market share in 2024, while wound closure products are forecast to grow at 5.32% CAGR through 2030.  
  • By wound type, chronic wounds accounted for 61.02% of the Netherlands wound care management devices market size in 2024, but acute wounds represent the fastest growth at 5.76% CAGR to 2030.  
  • By end user, hospitals and specialty clinics held 50.55% of the Netherlands wound care management devices market share in 2024; home healthcare settings exhibit the highest projected CAGR at 5.81% through 2030.  
  • By mode of purchase, institutional procurement captured 63.21% of the Netherlands wound care management devices market size in 2024, whereas retail and OTC channels are advancing at 5.96% CAGR to 2030.  

Segment Analysis

By Product: Broad Device Portfolios Command the Premium Tier

Wound care devices retained 67.44% share of the Netherlands wound care management devices market in 2024, led by foam dressings, hydrofibers, and negative-pressure platforms that provide superior exudate management and infection control. Smith+Nephew’s NPWT line contributed to 3.8% underlying revenue growth in its Advanced Wound Management division during Q1 2025. Clinical studies that position advanced dressings as cost-neutral over an episode of care are sustaining hospital demand even amid reimbursement scrutiny. Wound closure products account for smaller revenue but are expanding at 5.32% CAGR as staplers, sealants, and bioabsorbable clips gain favor in minimally invasive surgery. Sensor-integrated dressings that transmit temperature or pH data to clinicians are blurring category boundaries, enabling hybrid products that both close and monitor wounds.  

The Netherlands wound care management devices market size for wound closure solutions is set to climb as procedure volumes rise and surgeons seek devices that limit operative time while improving cosmetic results. Incorporation of antimicrobial coatings into sutures is lowering post-operative infection risk, aligning with hospital quality metrics. Biodegradable adhesives promise avoidance of removal procedures, adding patient convenience. In parallel, developers are embedding microelectronics into adhesives to create intelligent closures capable of reporting tension or moisture in real time, a capability valued by surgical teams pursuing enhanced recovery protocols.

Netherlands Wound Care Management Devices Market: Market Share by Product
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Wound Type: Chronic-Care Complexity Sustains Advanced Therapy Demand

Chronic wounds captured 61.02% of Netherlands wound care management devices market share in 2024, reflecting the cumulative effects of aging, vascular disease, and diabetes. Prevalence of pressure ulcers in institutionalized elderly patients drives perpetual consumption of foam and antimicrobial dressings, while NPWT shortens closure timelines for recalcitrant diabetic ulcers. Frailty assessments reveal higher-than-expected care complexity, necessitating technologies that simplify dressing changes and enable caregivers with limited wound expertise. The Netherlands wound care management devices market size for chronic wounds is projected to grow steadily as the population aged 65 + rises and comorbid conditions accumulate.

Acute wounds are forecast to expand faster at 5.76% CAGR, riding on surgical volume growth and improved trauma survival rates. Prophylactic NPWT has demonstrated infection reductions of more than 50% in complex abdominal procedures, encouraging routine use in high-risk surgeries. Burns treatment for older adults remains resource-intensive, reinforcing demand for dressings that speed re-epithelialization while minimizing pain. The Netherlands wound care management devices industry increasingly couples acute-wound therapies with digital monitoring, allowing early intervention when complications emerge.

By End User: Home Healthcare Emergence Reshapes Care Delivery

Hospitals and specialty clinics retained 50.55% revenue share in 2024, yet the home-care channel grows 5.81% CAGR as digital monitoring underpins safe decentralisation. Luscii’s remote-care platform has already lowered cardiology outpatient visits by 19%; OMRON’s January-2025 takeover signals strategic intent to embed similar functionality in wound care workflows. Portable NPWT units approved for patient self-management enable same-day discharge, lowering inpatient bed-days and amplifying Netherlands wound care management devices market penetration beyond hospital walls.

Institutional facilities remain indispensable for complex or surgically intensive cases. AI-powered imaging tools have analysed 50 million wounds to date, supplying clinicians with healing-trajectory forecasts that refine treatment choice. As ageing deepens, long-term-care operators pilot sensor carpets and chair-pressure maps that alert nurses to shear or moisture risk, integrating wound prevention into everyday elder care.

Netherlands Wound Care Management Devices Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Mode of Purchase: Retail Growth Signals Patient Empowerment

Institutional procurement contributed 63.21% of 2024 revenue, mirroring strict professional oversight for advanced modalities. Value-based tenders now score bids on healing time, total cost and environmental footprint, lifting barriers for suppliers ready with lifecycle analyses. The Fast-Track protocol standardises triage, nudging GPs toward products with published algorithms and validated outcomes.

Retail and OTC channels climb at 5.96% CAGR as educated patients order silicagel sheets, hydrocolloids and smart dressings through e-commerce. Integrated tele-consultation services help customers photograph wounds and receive guidance, reinforcing adherence while shrinking travel costs. This consumer pivot enlarges the Netherlands wound care management devices market and forces manufacturers to package professional-grade performance in user-friendly formats.

Geography Analysis

Urban teaching hospitals in Amsterdam, Utrecht, and Rotterdam spearhead adoption of advanced wound care systems, enabled by research grants and robust clinical-trial infrastructure. These centers often pilot smart dressings and predictive analytics platforms before nationwide rollout, anchoring early revenue streams for innovators. Rural regions, by contrast, face shortages of certified wound-care nurses, prompting investment in telehealth to bridge expertise gaps. Implementation of the Fast-Track referral model nationwide has harmonized treatment pathways, yet rural clinics still confront longer travel times for specialist consultations, reinforcing the appeal of home-based NPWT units.

Government funding of EUR 600 million to expand nursing-home capacity beginning 2027 will concentrate new demand for institutional wound-care technologies outside the Randstad corridor. Facilities built under this program are being designed with sensor-enabled care suites, positioning them as early adopters of continuous monitoring systems. Recycling mandates appear most stringent in university hospitals, where sustainability offices track packaging waste as a procurement criterion, indirectly shaping supplier portfolios. Cross-border care agreements with Germany and Belgium facilitate knowledge exchange and joint clinical studies, benefiting Dutch suppliers that can prove efficacy in broader European populations.

The Netherlands wound care management devices market registers near-uniform reimbursement rules across provinces, yet local procurement collaboratives negotiate separate supply contracts that favor vendors able to guarantee just-in-time logistics. The national electronic-health-record backbone simplifies data collection for outcomes-based purchasing, giving device makers that offer integrated digital dashboards an advantage. Overall, regulatory coherence, high digital maturity, and demographic headwinds combine to create a fertile test bed for novel wound-management ecosystems.

Competitive Landscape

Multinational incumbents such as Smith+Nephew, ConvaTec, and Mölnlycke hold leading positions in the Netherlands wound care management devices market by coupling broad portfolios with established key-account teams. Smith+Nephew’s RENASYS EDGE rollout and 3.8% Q1 2025 revenue uptick demonstrate the resilience of premium NPWT lines. ConvaTec’s 2024 clinical study results showcased faster closure for its collagen-alginate dressings, reinforcing evidence-based marketing tactics. Mölnlycke leverages its Safetac silicone technology to secure formularies that prioritize atraumatic dressing removal.

Digital-health entrants, often spin-outs from Dutch universities, target gaps in real-time monitoring and predictive analytics. Plasmacure’s cold-plasma PLASOMA device, able to close wounds 2.5 times faster in clinical studies, positions the firm as a challenger with a differentiated modality. The acquisition of Luscii by OMRON Healthcare underscores rising interest from consumer-health giants in remote monitoring, potentially widening distribution channels for sensor-embedded dressings. Regulatory hurdles under the EU Medical Device Regulation favor well-capitalized players that can finance post-market surveillance and clinical evidence generation, but cloud-based software companies circumvent some hardware burdens, accelerating their go-to-market path.

Competitive battlegrounds increasingly coalesce around sustainability credentials and outcome-based pricing. Suppliers that reclaim NPWT pumps for refurbishment, or offer bio-based dressings that satisfy plastic-reduction targets, are gaining tender advantages. Hospitals award multi-year contracts contingent on healing-rate guarantees, prompting vendors to bundle devices, consumables, and analytics in integrated platforms. White-space opportunities include machine-learning wound-scoring engines, compostable absorbent layers, and end-to-end logistics services that reduce caregiver workload while improving healing trajectories.

Netherlands Wound Care Management Devices Industry Leaders

  1. ConvaTec

  2. Smith & Nephew

  3. Medtronic

  4. Solventum

  5. Coloplast

  6. *Disclaimer: Major Players sorted in no particular order
nether.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: Plasmacure signed a development and distribution agreement with Venture Medical for its PLASOMA cold-plasma chronic-wound system.
  • December 2024: UMC Utrecht and TU Delft unveiled WOCA, a low-cost portable NPWT device built on Arduino technology for trials in low-resource settings.
  • September 2024: Plasmacure reported clinical data showing PLASOMA closes 2.5 times more wounds than standard care.

Table of Contents for Netherlands Wound Care Management Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing incidence of chronic wounds & diabetic ulcers
    • 4.2.2 Rising surgical procedure volumes
    • 4.2.3 Rapidly expanding ageing population
    • 4.2.4 Uptake of negative-pressure & smart-sensor wound-therapy devices
    • 4.2.5 National Fast-Track protocol accelerating specialist referrals
    • 4.2.6 Sustainability push for bio-based, compostable dressings
  • 4.3 Market Restraints
    • 4.3.1 High total treatment cost for advanced modalities
    • 4.3.2 Stringent reimbursement approval in Dutch basic-insurance system
    • 4.3.3 Shortage of certified wound-care nurses
    • 4.3.4 Environmental restrictions on single-use plastics in hospitals
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porters Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product
    • 5.1.1 Wound Care
    • 5.1.1.1 Dressings
    • 5.1.1.1.1 Traditional Gauze & Tape Dressings
    • 5.1.1.1.2 Advanced Dressings
    • 5.1.1.2 Wound-Care Devices
    • 5.1.1.2.1 Negative Pressure Wound Therapy (NPWT)
    • 5.1.1.2.2 Oxygen & Hyperbaric Systems
    • 5.1.1.2.3 Electrical Stimulation Devices
    • 5.1.1.2.4 Other Wound Care Devices
    • 5.1.1.3 Other Wound Care Products
    • 5.1.2 Wound Closure
    • 5.1.2.1 Sutures
    • 5.1.2.2 Surgical Staplers
    • 5.1.2.3 Tissue Adhesives, Strips, Sealants & Glues
  • 5.2 By Wound Type
    • 5.2.1 Chronic Wounds
    • 5.2.1.1 Diabetic Foot Ulcer
    • 5.2.1.2 Pressure Ulcer
    • 5.2.1.3 Venous Leg Ulcer
    • 5.2.1.4 Other Chronic Wounds
    • 5.2.2 Acute Wounds
    • 5.2.2.1 Surgical/Traumatic Wounds
    • 5.2.2.2 Burns
    • 5.2.2.3 Other Acute Wounds
  • 5.3 By End User
    • 5.3.1 Hospitals & Specialty Wound Clinics
    • 5.3.2 Long-term Care Facilities
    • 5.3.3 Home-Healthcare Settings
  • 5.4 By Mode of Purchase
    • 5.4.1 Institutional Procurement
    • 5.4.2 Retail / OTC Channel

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Solventum
    • 6.3.2 Smith & Nephew plc
    • 6.3.3 Molnlycke Health Care AB
    • 6.3.4 B. Braun Melsungen AG
    • 6.3.5 ConvaTec Group plc
    • 6.3.6 Johnson & Johnson (Ethicon)
    • 6.3.7 Medtronic plc
    • 6.3.8 Lohmann & Rauscher GmbH
    • 6.3.9 Hollister Incorporated
    • 6.3.10 Integra LifeSciences
    • 6.3.11 Paul Hartmann AG
    • 6.3.12 Coloplast A/S
    • 6.3.13 Cardinal Health
    • 6.3.14 Urgo Medical
    • 6.3.15 Medela AG
    • 6.3.16 Essity (BSN medical)
    • 6.3.17 Organogenesis Inc.
    • 6.3.18 Stryker Corporation
    • 6.3.19 DermaRite Industries
    • 6.3.20 MiMedx Group
    • 6.3.21 DeRoyal Industries
    • 6.3.22 Bioventus LLC
    • 6.3.23 Kerecis Ehf.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

Our study defines the Netherlands wound-care management devices market as every single-use or reusable device, negative-pressure systems, advanced sensor dressings, debridement tools, and closure instruments designed to clean, protect, or close chronic and acute skin lesions in Dutch clinical or home settings.

Scope Exclusion: first-aid plasters sold solely as over-the-counter consumer goods are not included.

Segmentation Overview

  • By Product
    • Wound Care
      • Dressings
        • Traditional Gauze & Tape Dressings
        • Advanced Dressings
      • Wound-Care Devices
        • Negative Pressure Wound Therapy (NPWT)
        • Oxygen & Hyperbaric Systems
        • Electrical Stimulation Devices
        • Other Wound Care Devices
      • Other Wound Care Products
    • Wound Closure
      • Sutures
      • Surgical Staplers
      • Tissue Adhesives, Strips, Sealants & Glues
  • By Wound Type
    • Chronic Wounds
      • Diabetic Foot Ulcer
      • Pressure Ulcer
      • Venous Leg Ulcer
      • Other Chronic Wounds
    • Acute Wounds
      • Surgical/Traumatic Wounds
      • Burns
      • Other Acute Wounds
  • By End User
    • Hospitals & Specialty Wound Clinics
    • Long-term Care Facilities
    • Home-Healthcare Settings
  • By Mode of Purchase
    • Institutional Procurement
    • Retail / OTC Channel

Detailed Research Methodology and Data Validation

Primary Research

Our analysts held structured interviews with Dutch wound-care nurses, hospital procurement heads, and home-care coordinators across Randstad, North Brabant, and Friesland. These discussions validated average selling prices, NPWT penetration, and regional stock-outs that desk material alone could not surface.

Desk Research

We reviewed freely available tier-1 sources such as the Netherlands Central Bureau of Statistics surgical files, RIVM prevalence dashboards, Eurostat hospital-discharge data, International Diabetes Federation disease registers, and European Wound Management Association guidance. Patents from Questel and company statements in D&B Hoovers highlighted technology diffusion and pricing. Tenders Info notices plus EU-MDR filings confirmed installed base numbers. The sources named illustrate the breadth of our desk work; many additional references supported data checks.

Market-Sizing & Forecasting

We anchored 2025 value using a top-down prevalence-to-treated-cohort model, then corroborated totals with selective bottom-up supplier roll-ups. Core variables, diabetes incidence, elective surgery trends, geriatric population growth, NPWT adoption rates, and device replacement cycles feed a multivariate regression that extends forecasts to 2030. Where bottom-up numbers were patchy, we aligned outputs to hospital invoice audits before applying scenario analysis for reimbursement shifts.

Data Validation & Update Cycle

Model outputs face peer review and variance checks; anomalies trigger re-interviews. Reports refresh annually, with interim updates when material regulatory or recall events emerge.

Why Mordor's Netherlands Wound Care Management Baseline Commands Reliability

Published estimates vary because firms differ on scope, base year, and assumption depth. By focusing strictly on devices, selecting a 2025 anchor, and grounding inputs in Dutch usage metrics, Mordor Intelligence offers a balanced lens.

Key gap drivers elsewhere include mixing consumer dressings with devices, relying on global revenue splits, or isolating only advanced sub-segments.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 220.46 m (2025) Mordor Intelligence -
USD 349 m (2023) Regional Consultancy A Combines dressings, biologics, OTC items; older base year and revenue-share split model
USD 165 m (2025) Trade Journal B Counts export-import dressings only; excludes hospital devices
USD 182.85 m (2028) Global Consultancy C Looks solely at advanced segment; limited survey sample without national calibration

The comparison shows how Mordor Intelligence delivers a reproducible, transparent baseline rooted in current data and continuous validation, giving decision-makers a dependable starting point.

Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the Netherlands wound care management devices market?

The market stands at USD 220.46 million in 2025 and is set to reach USD 280.69 million by 2030.

Which product category holds the largest share?

Wound care devices, including advanced dressings and NPWT systems, hold 67.44% share of the Netherlands wound care management devices market.

How fast are home-healthcare applications growing?

Home-care use of wound devices is expanding at a 5.81% CAGR as telehealth and single-use NPWT enable safe treatment outside hospitals.

What is driving acute wound segment growth?

Rising surgical volumes and enhanced trauma care protocols are pushing the acute segment to a 5.76% CAGR through 2030.

How are sustainability rules affecting device procurement?

EU and Dutch bans on single-use plastics are pressuring hospitals to shift toward bio-based dressings and reusable NPWT pumps, reshaping supplier selection criteria.

Why are reimbursement approvals challenging for new devices?

The Dutch basic-insurance system demands strong clinical and economic evidence, extending timelines and raising the bar for advanced technologies seeking coverage.

Page last updated on:

Netherlands Wound Care Management Devices Market Report Snapshots